Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon Cancer - Frank A. Sinicrope; Fang-Shu Ou; Dirk Arnold; Walter R. Peters; Robert J. Behrens; Christopher H. Lieu; Khalid Matin; Deirdre J. Cohen; Samara L. Potter; Andrew B. Nixon; Lisa A Kottschade; Emily Kathol; et al. (New England Journal of Medicine, 2026)